Cargando…
γ-Glutamyl transferase 7 is a novel regulator of glioblastoma growth
BACKGROUND: Glioblastoma (GBM) is the most malignant primary brain tumor in adults, with a median survival time of one and a half years. Traditional treatments, including radiation, chemotherapy, and surgery, are not curative, making it imperative to find more effective treatments for this lethal di...
Autores principales: | Bui, Timothy T, Nitta, Ryan T, Kahn, Suzana A, Razavi, Seyed-Mostafa, Agarwal, Maya, Aujla, Parvir, Gholamin, Sharareh, Recht, Lawrence, Li, Gordon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4393868/ https://www.ncbi.nlm.nih.gov/pubmed/25884624 http://dx.doi.org/10.1186/s12885-015-1232-y |
Ejemplares similares
-
Immune Evasion Strategies of Glioblastoma
por: Razavi, Seyed-Mostafa, et al.
Publicado: (2016) -
γ-Glutamyl transferase and breast cancer risk
por: Fentiman, I S, et al.
Publicado: (2010) -
Casein Kinase 2α Regulates Glioblastoma Brain Tumor Initiating Cell Growth through the β-Catenin Pathway
por: Nitta, Ryan T., et al.
Publicado: (2014) -
Association of γ-glutamyl transferase with premature coronary artery disease
por: GHATGE, MADANKUMAR, et al.
Publicado: (2016) -
Serum alkaline phosphatase and γ-glutamyl transferase in acute pyelonephritis
por: Han, Chaehoon, et al.
Publicado: (2019)